ACP-HIP

N/A

Report date: 2024/01/19 15:04:11

Base Information

Drug NameACP-HIP
Drug Alias NamehCG derivative (Quest Pharma)ACP-HIP
ClassificationNatural product/Extract > Animal extractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsSarcoma, Kaposi
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesQuest Pharmatech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSarcoma, Kaposi

Other Information

ATC CodeN/A
Related LinksN/A